Clinical Microbiology Reviews

Papers
(The TQCC of Clinical Microbiology Reviews is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Transmission of Infections during Cardiopulmonary Resuscitation392
Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections225
Extracutaneous sporotrichosis188
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders181
Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values—laboratory and clinical utility158
The long reach of influenza and other respiratory viruses: from acute epithelial injury to post-viral lung disease138
Integrating whole-genome sequencing into antimicrobial resistance surveillance: methodologies, challenges, and perspectives133
Erratum for Nyaruaba et al., “Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks”129
Antibiotic tolerance among clinical isolates: mechanisms, detection, prevalence, and significance128
Progression of antibiotic resistance in Neisseria meningitidis120
Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options118
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant115
Membrane Technology for Rapid Point-of-Care Diagnostics for Parasitic Neglected Tropical Diseases102
Emerging hybrid shigatoxigenic and enteropathogenic Escherichia coli serotype O80:H2 in humans and calves93
The sex hormone-gut microbiome axis: mechanistic drivers of sex-disparate bacterial infection outcomes and precision clinical interventions89
Viral infections and pathogenesis of glaucoma: a comprehensive review88
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus85
Review of BCG immunotherapy for bladder cancer82
Intestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunities82
Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics81
Non- faecium non- faecalis enterococci: a review of clinical manifestations, virulence factors, and antimicrobial resistance79
A review of post-exposure strategies for high-consequence viral pathogens in the laboratory77
Canonical fact versus hypothesis testing to decipher transmission of non-tuberculous and tuberculous mycobacteria: a comparative review77
Decontamination approaches and strategies for the prevention of sink drain-related healthcare-associated infections75
Evolutionary Pathways and Trajectories in Antibiotic Resistance75
Extrapolation and comparison of West Nile virus- and Usutu virus-associated neurological diseases in humans: linking pathology to clinical symptoms74
Drug-resistant Acinetobacter baumannii : mortality, emerging treatments, and future pharmacological targets for a WHO priority pathogen70
Congenital Syphilis: a Review of Global Epidemiology69
Neisseria gonorrhoeae vaccines: a contemporary overview66
Clonorchiasis and opisthorchiasis: epidemiology, transmission, clinical features, morbidity, diagnosis, treatment, and control65
Erratum for Cho et al., “Recent advances in therapeutic probiotics: insights from human trials”64
Bacillus cereus Invasive Infections in Preterm Neonates: an Up-to-Date Review of the Literature62
Bacterial and fungal infections in persons who inject drugs59
BCG therapy in bladder cancer and its tumor microenvironment interactions58
Diagnosis, Management, and Future Control of Cholera57
The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections57
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease57
Rapid and accurate testing for urinary tract infection: new clothes for the emperor56
Aspergillus terreus Species Complex53
Trained Immunity as a Preventive Measure for Surgical Site Infections51
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes50
Harnessing the host response for precision infectious disease diagnosis49
Agnostic Sequencing for Detection of Viral Pathogens49
Lyme borreliosis in Brazil: a critical review on the Baggio–Yoshinari syndrome (Brazilian Lyme-like disease)48
Convalescent plasma for COVID-19: planning for the next pandemic using the worldwide experience48
Immunosuppressant imprecision: multidirectional effects on metabolism and microbiome48
2021 Acknowledgment of CMR Reviewers47
Artemisinin-resistant malaria47
Editorial Board43
COVID-19 therapeutics42
0.052716970443726